Mode
Text Size
Log in / Sign up

Lignocaine-based opioid-free anesthesia increases sevoflurane need in head-and-neck cancer surgeryOpioid-free surgery needs more gas to keep patients asleep safely

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that lignocaine-based opioid-free anesthesia may increase sevoflurane requirements and hypertension risk compared to morphine-based anesthesia in head-and-neck cancer surgery.

This randomized trial compared a lignocaine-based opioid-free anesthesia (OFA) regimen with a morphine-based regimen in 30 patients undergoing wide excision and reconstruction for head-and-neck cancer. The lignocaine group received a bolus of 1.5 mg/kg and infusion of 1 mg/kg/h, while the morphine group received a bolus of 0.2 mg/kg and infusion of 2 mg/h. The primary outcome was the end-tidal sevoflurane concentration needed to maintain bispectral index (BIS) values of 40-60.

The study found that the lignocaine-based OFA group required significantly higher end-tidal sevoflurane concentrations and had higher sevoflurane consumption compared to the morphine group. Additionally, hypertension was significantly more frequent in the lignocaine group, and more patients required additional analgesics. Heart rate was higher immediately after induction and at 1 minute postintubation in the lignocaine group, but lower at 60 minutes postintubation. No intraoperative awareness was reported in either group.

Safety data were limited; hypertension was noted as an adverse event, but serious adverse events, discontinuations, and tolerability were not reported. The small sample size and lack of blinding or detailed methodology limit the strength of these findings. Clinicians should interpret these results cautiously, as the study suggests that lignocaine-based OFA may not reduce anesthetic requirements and could increase hemodynamic instability in this surgical population.

Imagine walking into the operating room feeling calm but needing to stay perfectly still. You trust the medical team to keep you asleep and pain-free. But what happens if the drugs used to keep you comfortable do not work exactly as planned?

Doctors are trying to stop patients from getting addicted to opioids like morphine. They want to use other medicines to manage pain without those risks. This new research looks at one specific swap: replacing morphine with lignocaine.

Lignocaine is a common numbing drug. It blocks pain signals well. However, this study found that swapping it for morphine changes how the anesthesia machine must work. The team needed to adjust the breathing gas to keep patients safe.

The Old Way Vs The New Way

For years, doctors relied on morphine to keep patients comfortable during big surgeries. Morphine is an opioid. It works very well for pain but carries addiction risks. Now, many hospitals try to avoid these drugs entirely.

This approach is called opioid-free anesthesia. It uses different medicines to handle pain. The goal is to give patients the same comfort without the long-term dangers of opioids. But changing the drug mix is not simple.

But here is the twist. When doctors used lignocaine instead of morphine, the patients reacted differently. Their bodies needed more of the main sleeping gas to stay asleep. This was not what the doctors expected when they started the trial.

A Factory That Needs More Fuel

Think of the brain like a busy factory floor. Anesthesia is the manager telling workers to stop and rest. The manager uses a signal to tell the factory to shut down.

In this study, the lignocaine group needed a louder signal to keep the factory quiet. The sevoflurane gas acts like fuel for that signal. The lignocaine group burned through more fuel to stay asleep. The morphine group used less fuel to reach the same level of rest.

This difference matters because the breathing machine must deliver more gas to the patient. If the machine does not deliver enough, the patient might wake up or feel pain. The study showed that the lignocaine group needed significantly higher concentrations of sevoflurane.

The researchers studied thirty patients with head-and-neck cancer. These patients needed wide excision and reconstruction. That is a very big operation involving cutting and rebuilding tissue in the face and neck area.

Half the group got lignocaine. The other half got morphine. Both groups used propofol to fall asleep initially. The doctors watched the brain activity closely to ensure everyone stayed asleep.

The results were clear. The lignocaine group needed more sevoflurane gas. They also had higher blood pressure more often. Doctors had to give extra pain medicines to control that pressure. The heart rate was also higher in the lignocaine group right after the doctors put the breathing tube in.

This doesn't mean this treatment is available yet.

Neither group reported waking up during the surgery. That is a huge safety win. Both methods kept patients unconscious and unaware. The main difference was how much gas was needed and how the blood pressure behaved.

If you or a loved one needs this type of surgery, talk to your surgeon about the plan. They will decide which drug mix is best for your specific case. Some patients might do better with morphine. Others might prefer to avoid opioids if possible.

The key is that the anesthesia team must adjust the gas levels carefully. They cannot use a standard setting for both groups. The machine must be tuned to the specific drugs being used. This ensures the patient stays safe and comfortable.

This study was small with only thirty patients. It focused on one specific type of cancer surgery. Results might differ for other operations or other types of patients. More research is needed to see if this works for everyone.

Doctors will likely continue to test these different drug combinations. They want to find the safest way to avoid opioids while keeping patients comfortable. Until then, the choice depends on the surgeon and the patient.

The field of anesthesia is moving fast. New ways to manage pain are always being tested. This study adds important data to that growing list. It shows that swapping drugs changes the whole picture. The team must be ready to adapt quickly to keep patients safe.

Study Details

Study typeRct
Sample sizen = 30
EvidenceLevel 2
PublishedMay 2026
View Original Abstract ↓
BACKGROUND AND AIMS: In opioid-free anesthesia (OFA) protocol, intravenous lignocaine can offer perioperative analgesic benefits. However, maintaining adequate anesthetic depth during OFA, particularly with neuromuscular blockade, poses a challenge due to the unreliable nature of hemodynamic parameters as indicators of anesthetic depth. We aimed to compare the end-tidal sevoflurane concentration needed to maintain bispectral index (BIS) values of 40-60 in patients undergoing major head-and-neck cancer surgery using lignocaine-based OFA versus a morphine-based regimen. METHODS: This prospective, randomized, double-blind study enrolled 30 patients undergoing wide excision and reconstruction for head-and-neck cancer. Group L received a lignocaine bolus (1.5 mg/kg) and infusion (1 mg/kg/h), while Group B received a morphine bolus (0.2 mg/kg) and 2 mg/h infusion. Propofol was used to induce anesthesia, and nasal intubation was carried out. Sevoflurane in a 1:1 air-oxygen mixture was used for maintenance, titrated to maintain BIS values between 40 and 60. Additional analgesics were added if indicated. RESULTS: End-tidal sevoflurane concentration and sevoflurane consumption were significantly higher in Group L. Hypertension was significantly more frequent in Group L and required significantly more additional analgesics ( P < 0.001). Mean heart rate was higher in Group L immediately after induction and at 1 min postintubation, while it was lower at 60 min postintubation. Neither group reported any incidence of intraoperative awareness. CONCLUSION: Lignocaine-based OFA required a significantly higher end-tidal sevoflurane to maintain sufficient anesthetic depth compared to morphine-based anesthesia. In addition, sevoflurane use, intraoperative hypertension, and the need for supplemental analgesics were notably greater in the OFA group.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.